Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer (Q66406368)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer |
clinical trial |
Statements
A Pilot and Phase II Study to Assess the Safety, Tolerability and Efficacy of Pembrolizumab Plus Chemotherapy in Metastatic Triple Negative Breast Cancer Patients (English)
0 references
23 February 2016
0 references
May 2021
0 references
88
0 references
18 year
0 references